Details for: RFC1
Gene ID: 5981
Gene Type: Protein-coding - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.
Symbol: RFC1
Ensembl ID: ENSG00000035928
Description: replication factor C subunit 1
Selected Context(s): Overall
Cell Significance Landscape
Associated with
Significant Cells
Cell Significance Index (CSI) scores for the chosen context(s)
-
CSI 14.8rCSI 23.82%PRS 25.67
-
CSI 13.39rCSI 18.94%PRS 42.84
-
CSI 13.28rCSI 12.28%PRS 52.86
-
CSI 12.23rCSI 17.34%PRS 30.68
-
CSI 12.01rCSI 9.08%PRS 43.83
-
CSI 10.53rCSI 16.18%PRS 38.67
-
CSI 8.85rCSI 11.11%PRS 41.42
-
CSI 7.05rCSI 15.44%PRS 42.24
-
CSI 6.78rCSI 17.91%PRS 38.83
-
CSI 6.34rCSI 7.89%PRS 43.66
-
CSI 6.02rCSI 17.19%PRS 48.4
-
CSI 5.75rCSI 4.46%PRS 32.46
-
CSI 5.71rCSI 12.81%PRS 21.35
-
CSI 5.66rCSI 3.94%PRS 44.35
-
CSI 5.62rCSI 6.78%PRS 39.23
-
CSI 5.59rCSI 4.54%PRS 33.81
-
CSI 5.44rCSI 21.17%PRS 51.72
-
CSI 5.34rCSI 4.49%PRS 48.73
-
CSI 5.27rCSI 7.59%PRS 42.64
-
CSI 5.17rCSI 26.68%PRS 56.37
-
CSI 5.12rCSI 30.16%PRS 21.89
-
CSI 5.11rCSI 4.06%PRS 53.58
-
CSI 5.09rCSI 4.9%PRS 33.7
-
CSI 4.79rCSI 8.04%PRS 20.81
-
CSI 4.79rCSI 5%PRS 66.88
-
CSI 4.78rCSI 21.26%PRS 31.63
-
CSI 4.75rCSI 13.5%PRS 34.49
-
CSI 4.53rCSI 19.89%PRS 53.02
-
CSI 4.52rCSI 10.3%PRS 32.48
-
CSI 4.43rCSI 22.22%PRS 42.22
-
CSI 4.42rCSI 6.05%PRS 31.48
-
CSI 4.36rCSI 8.75%PRS 24.94
-
CSI 4.13rCSI 14.85%PRS 19.79
-
CSI 3.87rCSI 9.25%PRS 44.73
-
CSI 3.67rCSI 2.16%PRS 45.39
-
CSI 3.66rCSI 4.87%PRS 36.33
-
CSI 3.65rCSI 6.45%PRS 20.14
-
CSI 3.64rCSI 2.94%PRS 33.15
-
CSI 3.62rCSI 4.92%PRS 61.69
-
CSI 3.56rCSI 5.73%PRS 22.56
-
CSI 3.56rCSI 10.21%PRS 48.04
-
CSI 3.49rCSI 11.18%PRS 41.64
-
CSI 3.41rCSI 8.1%PRS 38.62
-
CSI 3.41rCSI 9.36%PRS 48.92
-
CSI 3.32rCSI 3.42%PRS 49.27
-
CSI 3.24rCSI 4.77%PRS 30.57
-
CSI 3.22rCSI 6.42%PRS 50.44
-
CSI 3.18rCSI 8.09%PRS 31
-
CSI 3.16rCSI 2.76%PRS 42.02
-
CSI 3.15rCSI 2.52%PRS 53.34
-
CSI 3.07rCSI 13.28%PRS 50.45
-
CSI 3.06rCSI 2.28%PRS 50.59
-
CSI 3.01rCSI 4.12%PRS 36.81
-
CSI 3rCSI 2.83%PRS 34.01
-
CSI 2.93rCSI 8.49%PRS 35.76
-
CSI 2.93rCSI 3.51%PRS 51.35
-
CSI 2.91rCSI 11.25%PRS 53.42
-
CSI 2.86rCSI 13.71%PRS 30.78
-
CSI 2.83rCSI 2.24%PRS 23.18
-
CSI 2.68rCSI 4.13%PRS 31.15
-
CSI 2.67rCSI 2.21%PRS 33.5
-
CSI 2.66rCSI 1.77%PRS 37.21
-
CSI 2.62rCSI 16.37%PRS 27.13
-
CSI 2.58rCSI 5.89%PRS 28.33
-
CSI 2.57rCSI 6.5%PRS 39.96
-
CSI 2.55rCSI 7.96%PRS 23.53
-
CSI 2.54rCSI 1.82%PRS 43.95
-
CSI 2.53rCSI 1.76%PRS 39.6
-
CSI 2.52rCSI 1.87%PRS 45.14
-
CSI 2.49rCSI 42.12%PRS 70.76
-
CSI 2.48rCSI 3.66%PRS 37.05
-
CSI 2.42rCSI 2.12%PRS 37.36
-
CSI 2.4rCSI 2.46%PRS 51.6
-
CSI 2.39rCSI 3.25%PRS 28.35
-
CSI 2.39rCSI 1.82%PRS 42.48
-
CSI 2.36rCSI 7.6%PRS 33.53
-
CSI 2.32rCSI 5.44%PRS 43.16
-
CSI 2.3rCSI 2.95%PRS 31.46
-
CSI 2.3rCSI 7.35%PRS 29.95
-
CSI 2.29rCSI 1.81%PRS 38.62
-
CSI 2.29rCSI 3.17%PRS 39.81
-
CSI 2.27rCSI 1.75%PRS 31.35
-
CSI 2.26rCSI 3.45%PRS 41.22
-
CSI 2.23rCSI 3.1%PRS 33.05
-
CSI 2.2rCSI 10.09%PRS 56.37
-
CSI 2.19rCSI 4.81%PRS 36.59
-
CSI 2.16rCSI 2.54%PRS 45.82
-
CSI 2.15rCSI 1.45%PRS 41
-
CSI 2.14rCSI 1.43%PRS 61.02
-
CSI 2.12rCSI 3.37%PRS 41.79
-
CSI 2.12rCSI 1.65%PRS 47.43
-
CSI 2.12rCSI 2.84%PRS 40.33
-
CSI 2.12rCSI 1.48%PRS 34.52
-
CSI 2.12rCSI 4.84%PRS 32.43
-
CSI 2.11rCSI 1.58%PRS 68.1
-
CSI 2.1rCSI 2.68%PRS 37.53
-
CSI 2.07rCSI 1.74%PRS 37.78
-
CSI 2.07rCSI 4.97%PRS 50.45
-
CSI 2.06rCSI 2.81%PRS 35.58
-
CSI 2.04rCSI 1.51%PRS 28.31
-
CSI 0.1rCSI 1.1%PRS 50.4%
-
CSI 0.1rCSI 1.5%PRS 54.1%
-
CSI 0.2rCSI 2.9%PRS 73.5%
-
CSI 0.2rCSI 1.8%PRS 62.8%
-
CSI 0.2rCSI 1.2%PRS 45.1%
-
CSI 0.2rCSI 4.4%PRS 29.1%
-
CSI 0.2rCSI 3.4%PRS 27.5%
-
CSI 0.3rCSI 3.6%PRS 68.8%
-
CSI 0.3rCSI 5.7%PRS 27.9%
-
CSI 0.3rCSI 1.6%PRS 44.1%
-
CSI 0.3rCSI 1.2%PRS 21.6%
-
CSI 0.3rCSI 2.2%PRS 65.6%
-
CSI 0.4rCSI 2.9%PRS 52.4%
-
CSI 0.4rCSI 2.3%PRS 44.5%
-
CSI 0.4rCSI 0.6%PRS 47.7%
-
CSI 0.4rCSI 1.0%PRS 20.2%
-
CSI 0.4rCSI 1.3%PRS 21.8%
-
CSI 0.4rCSI 0.8%PRS 47.9%
-
CSI 0.4rCSI 2.3%PRS 58.5%
-
CSI 0.5rCSI 1.6%PRS 49.4%
-
CSI 0.5rCSI 1.3%PRS 26.4%
-
CSI 0.5rCSI 2.0%PRS 79.9%
-
CSI 0.5rCSI 11.2%PRS 21.0%
-
CSI 0.5rCSI 2.2%PRS 28.6%
-
CSI 0.5rCSI 1.0%PRS 61.5%
-
CSI 0.5rCSI 2.5%PRS 42.9%
-
CSI 0.5rCSI 1.2%PRS 30.5%
-
CSI 0.5rCSI 2.1%PRS 49.1%
-
CSI 0.6rCSI 2.7%PRS 58.1%
-
CSI 0.6rCSI 1.6%PRS 41.4%
-
CSI 0.6rCSI 1.3%PRS 47.6%
-
CSI 0.6rCSI 4.7%PRS 23.1%
-
CSI 0.7rCSI 1.0%PRS 34.0%
-
CSI 0.7rCSI 3.0%PRS 66.7%
-
CSI 0.7rCSI 2.4%PRS 72.0%
-
CSI 0.7rCSI 2.5%PRS 50.9%
-
CSI 0.7rCSI 1.2%PRS 31.2%
-
CSI 0.7rCSI 1.8%PRS 25.7%
-
CSI 0.7rCSI 1.7%PRS 45.1%
-
CSI 0.7rCSI 1.7%PRS 49.0%
-
CSI 0.7rCSI 1.5%PRS 42.3%
-
CSI 0.7rCSI 1.1%PRS 26.2%
-
CSI 0.8rCSI 3.6%PRS 36.5%
-
CSI 0.8rCSI 0.9%PRS 34.0%
-
CSI 0.8rCSI 1.3%PRS 25.9%
-
CSI 0.8rCSI 19.2%PRS 20.2%
-
CSI 0.8rCSI 1.6%PRS 34.1%
-
CSI 0.8rCSI 0.9%PRS 43.5%
-
CSI 0.8rCSI 0.9%PRS 33.2%
-
CSI 0.9rCSI 1.9%PRS 24.0%
-
CSI 0.9rCSI 0.9%PRS 38.1%
-
CSI 0.9rCSI 2.2%PRS 33.2%
-
CSI 0.9rCSI 1.8%PRS 55.3%
-
CSI 0.9rCSI 2.3%PRS 46.1%
-
CSI 0.9rCSI 1.3%PRS 46.7%
-
CSI 0.9rCSI 1.5%PRS 41.9%
-
CSI 0.9rCSI 5.4%PRS 37.1%
-
CSI 1.0rCSI 1.8%PRS 63.0%
-
CSI 1.0rCSI 1.7%PRS 61.9%
-
CSI 1.0rCSI 1.2%PRS 51.9%
-
CSI 1.0rCSI 2.8%PRS 47.5%
-
CSI 1.0rCSI 1.7%PRS 35.8%
-
CSI 1.0rCSI 2.1%PRS 33.2%
-
CSI 1.1rCSI 1.5%PRS 42.2%
-
CSI 1.1rCSI 1.4%PRS 44.2%
-
CSI 1.1rCSI 5.7%PRS 48.2%
-
CSI 1.1rCSI 1.7%PRS 37.1%
-
CSI 1.1rCSI 1.0%PRS 40.7%
-
CSI 1.1rCSI 1.8%PRS 33.5%
-
CSI 1.1rCSI 1.1%PRS 57.2%
-
CSI 1.1rCSI 3.2%PRS 51.0%
-
CSI 1.1rCSI 1.3%PRS 36.5%
-
CSI 1.1rCSI 2.9%PRS 30.2%
-
CSI 1.1rCSI 1.7%PRS 35.0%
-
CSI 1.2rCSI 4.5%PRS 42.5%
-
CSI 1.2rCSI 1.3%PRS 24.9%
-
CSI 1.2rCSI 1.8%PRS 49.1%
-
CSI 1.2rCSI 3.0%PRS 65.8%
-
CSI 1.2rCSI 3.1%PRS 55.9%
-
CSI 1.2rCSI 1.8%PRS 48.6%
-
CSI 1.2rCSI 1.6%PRS 34.8%
-
CSI 1.2rCSI 3.9%PRS 37.0%
-
CSI 1.2rCSI 2.7%PRS 46.8%
-
CSI 1.2rCSI 2.8%PRS 39.5%
-
CSI 1.2rCSI 3.5%PRS 36.4%
-
CSI 1.2rCSI 1.5%PRS 20.7%
-
CSI 1.2rCSI 1.9%PRS 43.7%
-
CSI 1.2rCSI 2.2%PRS 27.7%
-
CSI 1.2rCSI 3.7%PRS 37.6%
-
CSI 1.3rCSI 1.1%PRS 36.3%
-
CSI 1.3rCSI 2.4%PRS 57.1%
-
CSI 1.3rCSI 3.1%PRS 44.1%
-
CSI 1.3rCSI 1.7%PRS 44.8%
-
CSI 1.3rCSI 2.5%PRS 69.0%
-
CSI 1.3rCSI 2.9%PRS 38.2%
-
CSI 1.3rCSI 3.0%PRS 27.2%
-
CSI 1.4rCSI 1.5%PRS 36.5%
-
CSI 1.4rCSI 1.3%PRS 34.0%
-
CSI 1.4rCSI 1.9%PRS 45.4%
-
CSI 1.4rCSI 2.6%PRS 41.4%
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration
Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.
Legend:
- Query Gene
-
Node Color (Target Cell CSI, relative to current network):
- Very High
- High
- Medium
- Low
- Very Low
- CSI N/A
- Node Size: Proportional to Target Cell CSI magnitude
- STRING PPI Edge
- Shared Pathway Edge (ONTOLOGY)
Other Information
This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.
Genular Protein ID: 4003709449
Symbol: RFC1_HUMAN
Name: Replication factor C subunit 1
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 8248204
Title: cDNAs encoding the large subunit of human replication factor C.
PubMed ID: 8248204
PubMed ID: 8512577
Title: Cloning and expression of a novel human DNA binding protein, PO-GA.
PubMed ID: 8512577
PubMed ID: 7914507
Title: The human DNA-binding protein, PO-GA, is homologous to the large subunit of mouse replication factor C: regulation by alternate 3' processing of mRNA.
PubMed ID: 7914507
PubMed ID: 14702039
Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.
PubMed ID: 14702039
DOI: 10.1038/ng1285
PubMed ID: 15489334
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
PubMed ID: 15489334
DOI: 10.1101/gr.2596504
PubMed ID: 8999859
Title: Replication factor C interacts with the C-terminal side of proliferating cell nuclear antigen.
PubMed ID: 8999859
PubMed ID: 9705493
Title: DNA recognition properties of the N-terminal DNA binding domain within the large subunit of replication factor C.
PubMed ID: 9705493
PubMed ID: 17081983
Title: Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.
PubMed ID: 17081983
PubMed ID: 16964243
Title: A probability-based approach for high-throughput protein phosphorylation analysis and site localization.
PubMed ID: 16964243
DOI: 10.1038/nbt1240
PubMed ID: 17525332
Title: ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.
PubMed ID: 17525332
PubMed ID: 18669648
Title: A quantitative atlas of mitotic phosphorylation.
PubMed ID: 18669648
PubMed ID: 19413330
Title: Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.
PubMed ID: 19413330
DOI: 10.1021/ac9004309
PubMed ID: 19690332
Title: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.
PubMed ID: 19690332
PubMed ID: 20068231
Title: Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.
PubMed ID: 20068231
PubMed ID: 21269460
Title: Initial characterization of the human central proteome.
PubMed ID: 21269460
PubMed ID: 21406692
Title: System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.
PubMed ID: 21406692
PubMed ID: 23186163
Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.
PubMed ID: 23186163
DOI: 10.1021/pr300630k
PubMed ID: 24275569
Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.
PubMed ID: 24275569
PubMed ID: 25772364
Title: SUMO-2 orchestrates chromatin modifiers in response to DNA damage.
PubMed ID: 25772364
PubMed ID: 31230722
Title: Bioinformatics-Based Identification of Expanded Repeats: A Non-reference Intronic Pentamer Expansion in RFC1 Causes CANVAS.
PubMed ID: 31230722
PubMed ID: 30926972
Title: Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia.
PubMed ID: 30926972
Sequence Information:
- Length: 1148
- Mass: 128255
- Checksum: 485F0332FB56819B
- Sequence:
MDIRKFFGVI PSGKKLVSET VKKNEKTKSD EETLKAKKGI KEIKVNSSRK EDDFKQKQPS KKKRIIYDSD SESEETLQVK NAKKPPEKLP VSSKPGKISR QDPVTYISET DEEDDFMCKK AASKSKENGR STNSHLGTSN MKKNEENTKT KNKPLSPIKL TPTSVLDYFG TGSVQRSNKK MVASKRKELS QNTDESGLND EAIAKQLQLD EDAELERQLH EDEEFARTLA MLDEEPKTKK ARKDTEAGET FSSVQANLSK AEKHKYPHKV KTAQVSDERK SYSPRKQSKY ESSKESQQHS KSSADKIGEV SSPKASSKLA IMKRKEESSY KEIEPVASKR KENAIKLKGE TKTPKKTKSS PAKKESVSPE DSEKKRTNYQ AYRSYLNREG PKALGSKEIP KGAENCLEGL IFVITGVLES IERDEAKSLI ERYGGKVTGN VSKKTNYLVM GRDSGQSKSD KAAALGTKII DEDGLLNLIR TMPGKKSKYE IAVETEMKKE SKLERTPQKN VQGKRKISPS KKESESKKSR PTSKRDSLAK TIKKETDVFW KSLDFKEQVA EETSGDSKAR NLADDSSENK VENLLWVDKY KPTSLKTIIG QQGDQSCANK LLRWLRNWQK SSSEDKKHAA KFGKFSGKDD GSSFKAALLS GPPGVGKTTT ASLVCQELGY SYVELNASDT RSKSSLKAIV AESLNNTSIK GFYSNGAASS VSTKHALIMD EVDGMAGNED RGGIQELIGL IKHTKIPIIC MCNDRNHPKI RSLVHYCFDL RFQRPRVEQI KGAMMSIAFK EGLKIPPPAM NEIILGANQD IRQVLHNLSM WCARSKALTY DQAKADSHRA KKDIKMGPFD VARKVFAAGE ETAHMSLVDK SDLFFHDYSI APLFVQENYI HVKPVAAGGD MKKHLMLLSR AADSICDGDL VDSQIRSKQN WSLLPAQAIY ASVLPGELMR GYMTQFPTFP SWLGKHSSTG KHDRIVQDLA LHMSLRTYSS KRTVNMDYLS LLRDALVQPL TSQGVDGVQD VVALMDTYYL MKEDFENIME ISSWGGKPSP FSKLDPKVKA AFTRAYNKEA HLTPYSLQAI KASRHSTSPS LDSEYNEELN EDDSQSDEKD QDAIETDAMI KKKTKSSKPS KPEKDKEPRK GKGKSSKK